Zydus Cadila gets USFDA nod for anti-cholesterol drug Ruby Khatun Khatun1 May 2017 9:40 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market an anti-cholesterol drug, Cholestyramine, in the...
Himalaya aims Rs 1,000 cr turnover from baby, mom care products Ruby Khatun Khatun1 May 2017 9:35 AM ISTNew Delhi: Homegrown holistic wellness firm Himalaya Drug Company is eyeing Rs 1,000-crore annual turnover from its baby and mother care portfolio in...
FDA warns Divis Laboratories over data integrity issues at Vizag unit Ruby Khatun Khatun1 May 2017 9:01 AM ISTNew Delhi: Data integrity issues, including failure to prevent unauthorised access to laboratory records, are among issues cited by the USFDA in its...
Lupin gets three observations from USFDA for Goa plant supriya kashyap kashyap30 April 2017 10:25 AM ISTNew Delhi : Drug firm Lupin said the US health regulator FDA has issued three observations after inspecting its Goa plant."Recently the company's...
Novartis to speed up bid for MS drug approval, changes target Ruby Khatun Khatun30 April 2017 10:20 AM ISTNovartis said on Tuesday it would accelerate its bid to win approval for its experimental multiple sclerosis (MS) drug BAF312 and said it was now...
Siemens Healthineers announces launch of first fully automated lab supriya kashyap kashyap30 April 2017 10:10 AM ISTNew Delhi : Siemens Healthineers has announced successful installation of India’s first fully automated Aptio Automation track with multi discipline...
Aurobindo Pharma completes acquisition of Portugal’s Generis supriya kashyap kashyap29 April 2017 12:48 PM ISTHyderabad : Aurobindo Pharma Ltd has completed the acquisition of Generis Farmaceutica S.A. in Portugal.In January this year, Hyderabad-based...
Dr Reddy's gets 11 observations from USFDA for Hyderabad plant supriya kashyap kashyap29 April 2017 11:57 AM ISTNew Delhi : Drug major Dr Reddy's Laboratories said the US health regulator has issued 11 observations after inspecting its manufacturing plant in...
Synairgen loses half its value as AstraZeneca dumps drug Ruby Khatun Khatun29 April 2017 11:45 AM ISTBritish biotech firm Synairgen lost nearly half its value on Thursday as partner AstraZeneca pulled the plug on an experimental drug designed to help...
Cipla plea in High Court against change in price of asthma drugs supriya kashyap kashyap29 April 2017 11:34 AM ISTNew Delhi : The Delhi High Court sought the Centre's response on a plea by pharma major Cipla against a notification capping the prices of the...
Vancomycin Etoposide Noradrenaline Digoxin and other comes under price control : NPPA supriya kashyap kashyap29 April 2017 11:29 AM ISTNew Delhi : The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices of 15 more drugs, including those used for treatment of...
Tymlos New osteoporosis drug gets FDA approval : Radius Health's supriya kashyap kashyap29 April 2017 10:51 AM ISTThe U.S. Food and Drug Administration approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or...
